{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:01Z","timestamp":1790258341776,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.juro.2017.11.074","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T03:00:46Z","timestamp":1511492446000},"page":"1182-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect"],"prefix":"10.1097","volume":"199","author":[{"given":"Nathan","family":"Perlis","sequence":"first","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamir","family":"Al-Kasab","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardalan","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estee","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Fadak","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Sayid","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Zlotta","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Urology, Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeet","family":"Ghai","sequence":"additional","affiliation":[{"name":"Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.11.074_bib1","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2017.11.074_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2017.11.074_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.074_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","article-title":"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005","volume":"69","author":"Makarov","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.11.074_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gr\u00f6nberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2017.11.074_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2214\/AJR.07.2211","article-title":"Combined T2-weighted and diffusion-weighted mpMRI for localization of prostate cancer","volume":"189","author":"Haider","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.juro.2017.11.074_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.6004\/jnccn.2016.0060","article-title":"NCCN Guidelines insights: prostate cancer early detection, version 2","volume":"14","author":"Carroll","year":"2016","journal-title":"J Natl Compr Cancer Network"},{"key":"10.1016\/j.juro.2017.11.074_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2017.11.074_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.074_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.074_bib11","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-14-3334","article-title":"Identification of a candidate gene panel for the early diagnosis of prostate cancer","volume":"21","author":"Leyten","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2017.11.074_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00345-015-1655-8","article-title":"Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer","volume":"34","author":"Kaufmann","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2017.11.074_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.urology.2016.08.022","article-title":"Risk stratification by urinary prostate cancer gene 3 testing before magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy among men with no history of biopsy","volume":"99","author":"Fenstermaker","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.11.074_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bju.13504","volume":"118","author":"De Luca","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.11.074_bib15","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.2214\/AJR.12.10173","article-title":"Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI","volume":"201","author":"Rosenkrantz","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.juro.2017.11.074_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2214\/AJR.13.10699","article-title":"Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI","volume":"202","author":"Rosenkrantz","year":"2014","journal-title":"AJR Am J Roentgenol"}],"updated-by":[{"DOI":"10.1016\/j.juro.2018.07.020","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000}}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717779700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717779700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.11.074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:05:14Z","timestamp":1651194314000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.11.074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1016\/j.juro.2017.11.074"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.074","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}